Different proliferative and apoptotic activity in peripheral versus central parts of human uterine leiomyomas

Gynecologic and Obstetric Investigation

Volumn 55, Issue 4, 2003, Pages 199-204

  Bourlev, Vladimir ^a   Pavlovitch, Stanislav ^a   Stygar, Denis ^a   Volkov, Nikolai ^a   Lindblom, Bo ^b   Olovsson, Matts ^b,c  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b UPPSALA UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Apoptosis; Cellular proliferation; Leiomyoma; Myometrium; Sex steroid receptors

Indexed keywords

ESTROGEN RECEPTOR; HORMONE RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; SEX HORMONE;

ADULT; APOPTOSIS; ARTICLE; CALCULATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MENSTRUAL CYCLE; MITOSIS; MITOSIS INDEX; MYOMETRIUM; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE LEVEL; UTERUS BIOPSY; UTERUS MYOMA;

ADULT; APOPTOSIS; CELL DIVISION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; LEIOMYOMA; MENSTRUAL CYCLE; MIDDLE AGED; MYOMETRIUM; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; UTERINE NEOPLASMS;

EID: 0042573990     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072074     Document Type: Article

References (25)

1. Wilcox LS, Koonin LM, Pokras R, Strauss LT, Xia Z, Peterson HB: Hysterectomy in the United States, 1988-1990. Obstet Gynecol 1994;83:549-655.
2. Stewart EA: Uterine fibroids. Lancet 2001;357:293-298.
3. Matsuo H, Maruo T, Samoto T: Increased expression of bcl-2 protein in human uterine leiomyoma and its up-regulation by progesterone. J Clin Endocrinol Metab 1997;83:293-299.
4. Englund K, Blanck A, Gustavsson I, Lundkvist U, Sjoblom P, Norgren A, Lindblom B: Sex steroid receptors in human myometrium and fibroids during the menstrual cycle and gonadotropin-releasing hormone treatment. J Clin Endocrinol Metab 1998;83:4092-4096.
5. Wu X, Blanck A, Olovsson M, Henriksen R, Lindblom B: Expression of Bcl-2, Bcl-x, Mcl-1, Bax and Bak in human uterine leiomyomas and myometrium during the menstrual cycle and after menopause. J Steroid Biochem Mol Biol 2002;80:77-83.
6. Wu X, Blanck A, Olovsson M, Möller B, Favini R, Lindblom B: Apoptosis, cellular proliferation and expression of p53 in human uterine leiomyomas and myometrium during the menstrual cycle and after menopause. Acta Obstet Gynecol Scand 2000;79:397-404.
7. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
8. Kawaguchi K, Fujii S, Konishi I, Nanbu Y, Nonogaki H, Mori T: Mitotic activity in uterine leiomyomas during the menstrual cycle. Am J Obstet Gynecol 1989;160:637-641.
9. Kawaguchi K, Fujii S, Konishi I, Iwai T, Nanbu Y, Nonogaki H, Ishikawa Y, Mori T: Immunohistochemical analysis of oestrogen receptors, progesterone receptors and Ki-67 in leiomyoma and myometrium during the menstrual cycle and pregnancy. Virchows Arch A Pathol Anat Histopathol 1991;419:309-315.
10. Shimomura Y, Matsuo H, Samoto T, Maruo T: Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma. J. Clin Endocrinol Metab 1998;83:2192-2198.
11. Nisolle M, Gillerot S, Casanas-Roux F, Squifflet J, Berlier M, Donnez J: Immunohistochemical study of the proliferation index, oestrogen receptors and progesterone receptors A and B in leiomyomas and normal myometrium during the menstrual cycle and under gonadotropin-releasing hormone agonist therapy. Hum Reprod 1999;14:2844-2850.
12. Mizutani T, Sugihara A, Nakamuro K, Terada N: Suppression of cell proliferation and induction of apoptosis in uterine leiomyoma by gonadotropin-releasing hormone agonist (leuprolide acetate). J Clin Endocrinol Metab 1998;83:1253-1255.
13. Vu K, Greenspan DL, Wu T-C, Zacur HA, Kurman RJ: Cellular proliferation, oestrogen receptor, progesterone receptor, and bcl-2 expression in GnRH agonist-treated uterine leiomyomas. Hum Pathol 1998;29:359-363.
14. Wyllie AH, Kerr JFR, Currie AR: Cell death: The significance of apoptosis. Int Rev Cytol 1980;68:251-306.
15. Englund K, Blanck A, Gustavsson I, Lundkvist U, Sjoblom P, Norgren A, Lindblom B: Sex steroid receptors in human myometrium and fibroids during the menstrual cycle and gonadotropin-releasing hormone treatment. J Clin Endocrinol Metab 1998;83:4092-4096.
16. Okulicz WC, Savasta SM, Hoberg LM, Longcope C: Immunofluorescent analysis of oestrogen induction of progesterone receptor in the rhesus uterus. Endocrinology 1989;8:39-43.
17. Newbold RR, DiAugustine RP, Risinger JI, EverittJI, Walmer DK, Parrott EC, Dixon D: Advances in uterine leiomyoma research: Conference overview, summary, and future research recommendations. Environ Health Perspect 2000;108(suppl 5):785-790.
18. Ichimura T, Kawamura N, Ito F, Shibata S, Minakuchi K, Tsujimura A, Umesaki N, Ogito S: Correlation between the growth of uterine leiomyomas end oestrogen and progesterone receptor content in needle biopsy specimens. Fertil Steril 1998;70:967-971.
19. Dixon D, He H, Haseman JK: Immunohistochemical localization of growth factors and their receptors in uterine leiomyomas and matched myometrium. Environ Health Perspect 2000;108(suppl 5):795-802.
20. Gustavsson I, Englund K, Faxén M, Sjöblom P, Lindblom B, Blanck A: Tissue differences but limited sex steroid responsiveness of c-fos and c-jun in human fibroids and myometrium. Mol Hum Reprod 2000;6:55-59.
21. Rein MS: Advances in uterine leiomyoma research: The progesterone hypothesis. Environ Health Perspect 2000;108(suppl 5):791-793.
22. Tilman AJ: The effect of the progestins on the mitotic activity of uterine fibromyomas. Int J Gynecol Pathol 1985;4:89-96.
23. Harrison-Woolrych M, Robinson R: Fibroid growth in response to high-dose progestogen. Fertil Steril 1995;64:191-192.
24. Rein MS, Barbieri RI, Friedman AJ: Progesterone. Critical role in the pathogenesis of uterine myomas. Am J Obstet Gynecol 1995;172:14-18.
25. Murphy AA, Kettel LM, Morales AJ, Roberts VJ, Yen SS: Regression of uterine leiomyomata in response to the antiprogesterone RU 486. J Clin Endocrinol Metab 1993;76:513-517.